Skip to main navigation Skip to search Skip to main content

Sulfa drugs strike more than once

  • Onisha G. Patel
  • , Eddy K. Mberu
  • , Alexis M. Nzila
  • , Ian G. Macreadie*
  • *Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

48 Scopus citations

Abstract

Sulfa drugs are well known blockers of folate synthesis, acting as competitive inhibitors of p-aminobenzoate (pABA). Their mimicry of pABA is so complete that they can also condense with 2-amino-4-hydroxy-6-hydroxymethyl-7,8 dihydropteridine pyrophosphate to form sulfa-dihydropteroate (sulfa-DHP), which are inhibitory through competition with dihydrofolate. This suggests that, in addition to dihydropteroate synthase, there are still undiscovered determinants involved in sulfa drug resistance. Furthermore, novel drugs based on the DHP analogues could be added to the armory of antifolate drugs.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalTrends in Parasitology
Volume20
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Bibliographical note

Funding Information:
We thank Lindsay Sparrow and Ross Fernley for their critical reading of this manuscript. A.N. and E.M. thank The Wellcome Trust of Great Britain for financial support (ref. no. 056769).

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Sulfa drugs strike more than once'. Together they form a unique fingerprint.

Cite this